These challenges can be summarized as the absence of robust epidemiological and clinical research on T1D, difficulties in making a correct diagnosis, and suspected mortality attributable to poor insulin access and therapeutic management (9, 13, 15, 16). The gene discussed is INS; the disease is type 1 diabetes mellitus.